Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Structure-function studies of the HIF-pVHL axis: Implications for disease

FY 2017-18

Summary
Take a deep breath! Just as your brain reminds you to breathe, every single cell in the human body can sense if there is enough oxygen to survive and can adapt to changes in oxygen levels thanks to oxygen-sensing proteins. This ability is necessary in all stages of life, from the formation of blood vessels during fetal development, to adaptation in high altitudes by increasing the number of red blood cells, and responding to blood vessel blockages. Yet, this process is not always to our advantage. The process of oxygen-sensing also allows for both malignant and benign tumours to maintain their impressive bulk, even as cells within the tumour become oxygen deprived. In other words, while a cell's response to oxygen levels is important for survival, these processes can also be hijacked during tumour formation to allow for rapid cell division. It is not surprising that the proteins involved in the cell's oxygen-sensing pathway are found to be defective in different types of cancer, including one major killer: kidney cancer. Our research is focused on the study of mutations found in these oxygen-sensing and response proteins, namely pVHL and HIFalpha. HIFalpha activates the oxygen-response pathway, while pVHL deactivates it. Together, these proteins fine tune the oxygen-response pathway and ensure that each cell is correctly measuring oxygen levels. However, such is not always the case. For example, pVHL is mutated in several diseases, including the polycythemia, which is a chronic condition of elevated red blood cell levels. HIFalpha is also mutated in patients with polycythemia and in tumours of the neuroendocrine system. Our studies are focused on how these protein mutations disrupt the oxygen signalling pathway. We hope that these studies will reveal why these mutations are disease-causing and can serve as a logical basis for the development of prognostic and therapeutic tools. In the process, our research will help gain further insight into how cells sense oxygen.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
376552
Name
Tarade Daniel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Structure-function studies of the HIF-pVHL axis: Implications for disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Biochemistry; Biophysics; Cancer; Cell Biology; Neuroendocrine Tumours; Oxygen Sensing; Polycythemia; Protein Crystallography; Structural Biology
Abstract
Take a deep breath! Just as your brain reminds you to breathe, every single cell in the human body can sense if there is enough oxygen to survive and can adapt to changes in oxygen levels thanks to oxygen-sensing proteins. This ability is necessary in all stages of life, from the formation of blood vessels during fetal development, to adaptation in high altitudes by increasing the number of red blood cells, and responding to blood vessel blockages. Yet, this process is not always to our advantage. The process of oxygen-sensing also allows for both malignant and benign tumours to maintain their impressive bulk, even as cells within the tumour become oxygen deprived. In other words, while a cell's response to oxygen levels is important for survival, these processes can also be hijacked during tumour formation to allow for rapid cell division. It is not surprising that the proteins involved in the cell's oxygen-sensing pathway are found to be defective in different types of cancer, including one major killer: kidney cancer. Our research is focused on the study of mutations found in these oxygen-sensing and response proteins, namely pVHL and HIFalpha. HIFalpha activates the oxygen-response pathway, while pVHL deactivates it. Together, these proteins fine tune the oxygen-response pathway and ensure that each cell is correctly measuring oxygen levels. However, such is not always the case. For example, pVHL is mutated in several diseases, including the polycythemia, which is a chronic condition of elevated red blood cell levels. HIFalpha is also mutated in patients with polycythemia and in tumours of the neuroendocrine system. Our studies are focused on how these protein mutations disrupt the oxygen signalling pathway. We hope that these studies will reveal why these mutations are disease-causing and can serve as a logical basis for the development of prognostic and therapeutic tools. In the process, our research will help gain further insight into how cells sense oxygen.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tarade, Daniel
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2017-18) | Canada Spends